The Danish drugmaker will test Anthropic's Claude Science models against research questions it has so far failed to crack.
Novo Nordisk names AWS its preferred cloud and AI partner, opening a London hub to speed drug discovery.
Novo Nordisk partners with provider data company H1 to bring AI to trial design, enrollment and site selection.